Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) outcomes are improving since the implementation of immunotherapy. However, objective response rates are still limited to a select group of patients. This is partly due to TNBC intrinsic immune evasive mechanisms and the lack of proper tumor microe...

Descripción completa

Detalles Bibliográficos
Autores principales: Llinàs-Arias, Pere, Íñiguez-Muñoz, Sandra, McCann, Kelly, Voorwerk, Leonie, Orozco, Javier I. J., Ensenyat-Mendez, Miquel, Sesé, Borja, DiNome, Maggie L., Marzese, Diego M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394958/
https://www.ncbi.nlm.nih.gov/pubmed/34439290
http://dx.doi.org/10.3390/cancers13164139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394958/
https://www.ncbi.nlm.nih.gov/pubmed/34439290
http://dx.doi.org/10.3390/cancers13164139

Ejemplares similares